 | Up a level |
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; ... (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. The lancet, 403(10441), pp. 2293-2306. Elsevier 10.1016/S0140-6736(24)00184-3
Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schliemann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; ... (2024). Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Annals of hematology, 103(5), pp. 1587-1599. Springer-Verlag 10.1007/s00277-023-05587-7
Aydilek, Enver; Wulf, Gerald; Schwarz, Friedrich; Bacher, Ulrike; Rummel, Mathias; Stiefel, Olga; Kerkhoff, Andrea; Maulhardt, Markus; Melchardt, Thomas; Pabst, Thomas; Lenz, Georg; Shumilov, Evgenii (2024). Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe. Cancer medicine, 13(10) Wiley 10.1002/cam4.7289
Berning, Philipp; Shumilov, Evgenii; Maulhardt, Markus; Boyadzhiev, Hristo; Kerkhoff, Andrea; Call, Simon; Reicherts, Christian; Saidy, Anna O.; Aydilek, Enver; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Schmitz, Norbert; Stelljes, Matthias; Wulf, Gerald; Bacher, Ulrike; Lenz, Georg; Pabst, Thomas Niklaus (2024). Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study. HemaSphere, 8(3), pp. 1-12. Wiley 10.1002/hem3.54
Krekeler, Carolin; Reitnauer, Lea; Bacher, Ulrike; Khandanpour, Cyrus; Steger, Leander; Boeckel, Göran Ramin; Klosner, Justine; Tepasse, Phil-Robin; Kemper, Marcel; Hennies, Marc Tim; Mesters, Rolf; Stelljes, Matthias; Schmitz, Norbert; Kerkhoff, Andrea; Schliemann, Christoph; Mikesch, Jan-Henrik; Schmidt, Nicole; Lenz, Georg; Bleckmann, Annalen and Shumilov, Evgenii (2022). Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario. Cancers, 14(22) MDPI AG 10.3390/cancers14225512
Shumilov, Evgenii; Aperdannier, Lena; Schmidt, Nicole; Szuszies, Christoph; Neesse, Albrecht; Hoffknecht, Petra; Khandanpour, Cyrus; Mikesch, Jan-Henrik; Stelljes, Matthias; Boeckel, Göran Ramin; Tepasse, Phil-Robin; Reitnauer, Lea; Koch, Raphael; Hasenkamp, Justin; Bacher, Ulrike; Scheithauer, Simone; Trümper, Lorenz; Schmitz, Norbert; Wulf, Gerald; Kerkhoff, Andrea; ... (2022). Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis. Cancers, 14(15) MDPI AG 10.3390/cancers14153746
Shumilov, Evgenii; Hoffknecht, Petra; Koch, Raphael; Peceny, Rudolf; Voigt, Steffen; Schmidt, Nicole; Peeck, Micha; Bacher, Ulrike; Scheithauer, Simone; Trümper, Lorenz; Lenz, Georg; Kerkhoff, Andrea; Bleckmann, Annalen (2021). Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers, 13(12) MDPI AG 10.3390/cancers13122917
Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; ... (2021). PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. The lancet oncology, 22(2), pp. 223-234. Elsevier 10.1016/S1470-2045(20)30601-X
